Center for Innovative Phage Applications

and Therapeutics

Hedieh Attai, PhD

Postdoctoral Scholar

1) Dwayne Roach, PhD - March 27, 2019, at UCSD

2) Chip Schooley, MD - April 24, 2019, at SDSU

3) Graham Hatful, PhD - May 29, 2019, at UCSD

4) David Pride, MD PhD - June 26, 2019, at SDSU

5) Katrine Whiteson, PhD - August 28, 2019, at SDSU

6) Vincent Fischetti, PhD - September 25, 2019, at UCSD

7) Justin Meyer, PhD - October 23, 2019, at SDSU

8) Forest Rohwer, PhD - November 20, 2019, at UCSD

9) Paul Bollyky, PhD - January 29, 2020, at SDSU

10) Rob Edwards, PhD - February 26, 2020, at UCSD

11) Ryland Young, PhD - August 19, 2020, at UCSD - To be rescheduled due to COVID-19

12) Kimberly Seed, PhD - September 23, 2020, at UCSD - On Hold due to COVID-19

13) Antoni Luque, PhD - October 28, 2020, at UCSD - On Hold due to COVID-19

Govind Sah, PhD

Postdoctoral Fellow

Leadership Team

Katrine Whiteson, PhD

Affiliate Member

The Center for Innovative Phage Applications and Therapeutics (IPATH) was founded in the UC San Diego School of Medicine in June 2018 with seed funding from UC San Diego Chancellor Pradeep Khosla. Our goal is to pursue, through collaboration with researchers, companies and institutions around the world, new treatments for combating antimicrobial resistant diseases—focusing on bacteriophage (phage) therapy. We have treated and will continue to treat patients with life-threatening multi-drug resistant infections with phage therapy through the FDA’s compassionate use program. We also strive to advance phage therapy into clinical trials so that it can be rigorously evaluated and if proven efficacious, become more widely available to combat the global superbug crisis.

Lina Huang, BS

Research Associate

Samuel Penziner, MD

Infectious Diseases Fellow

Claudia Sanchez-Ramirez, MD

Infectious Diseases Fellow

Steffanie Strathdee, PhD

Co-Director

Connie Benson, MD

Leadership Team

Translational Research In Bacteriophage Therapies Seminar Series

Dwayne Roach, PhD

Affiliate Member